Business Wire India

KASIKORNBANK (KBank) and Ant International have formed a strategic collaboration to jointly develop an integrated financial infrastructure to deliver faster, more reliable, and scalable payment experiences for Ant International and its customers.

 

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260528577525/en/

 

 

 

The Memorandum of Understanding (MoU) will combine KBank’s regulated financial capabilities with Ant International’s financial AI solutions to enable real-time, 24/7¹ cross-border USD transactions. The initiative will leverage Blockchain Deposit Accounts from Kinexys by J.P. Morgan, the industry-leading blockchain business part of J.P. Morgan Payments for real-time USD liquidity movement and is expected to significantly enhance transaction speed while enabling continuous 24/7² operations. KBank and Ant International will also use their best efforts to develop end-to-end solutions across payment acceptance, clearing, and settlement. These advancements remain subject to all necessary legal and regulatory approvals.

 

This collaboration will enhance Ant International’s inbound and outbound transaction and settlement efficiency, thus improving the business cashflow of the merchants the company serves.

 

 

This partnership builds on KBank’s existing collaboration with Ant International’s global payment services. Through Alipay+, Ant International’s digital wallet gateway, KBank’s mobile banking app KPLUS is connected into an ecosystem of 150 million merchants and 1.8 billion consumer accounts worldwide. KPLUS is also a growing payment option on Google Pay for Thai merchants through its integration with Antom, Ant International’s merchant payment service.

 

 

Dr. Karin Boonlertvanich, Executive Vice President of KASIKORNBANK, said, “This collaboration addresses a fundamental limitation in today’s cross-border financial systems, where liquidity movement remains constrained by fragmented infrastructure. By integrating blockchain with regulated financial systems, we are enabling a more continuous, transparent, and scalable flow of funds between global networks and local economies.”

 

 

Kelvin Li, General Manager of Platform Tech and Senior Vice President at Ant International, said, “Across emerging markets, industry leaders like KBank are preparing communities for a more interconnected global economy with broader and more secure application of AI and blockchain technology. We are thrilled to support KBank with such fintech solutions to empower Thai merchants – especially small businesses – with more efficient payment tools to thrive globally.”

 

 

This MOU underscores a shared commitment to the development of integrated and scalable cross-border financial systems, enhancing the efficiency and reliability of global payment systems for international commerce.

 

 

The development and potential implementation of this initiative will be undertaken in consultation with the relevant regulatory authorities, and will be subject to obtaining the necessary approvals prior to any live service deployment.

 

 

About KASIKORNBANK

 

 

KASIKORNBANK PUBLIC COMPANY LIMITED (KBank) operates under the vision of being a “Bank of Sustainability”, dedicated to delivering long-term value to all stakeholders through innovation, strong governance, and responsible growth. KBank continues to strengthen its leadership in digital banking through strategic initiatives that drive financial inclusion and cross-border interoperability, including the development of blockchain-based infrastructure and regulated on-chain payment ecosystems in partnership with global innovators.

 

 

About Ant International

 

 

Ant International is a leading global digital payment, digitisation and financial technology provider. Through collaboration across the private and public sectors, our unified techfin platform supports financial institutions and merchants of all sizes to achieve inclusive growth through a comprehensive range of cutting-edge digital payment and financial services solutions. To learn more, please visit https://www.ant-intl.com/

 

 

1 Transfers on the network are completed on a 24/7/365 and same day basis. Moving funds to and from the network from traditional Demand Deposit Accounts on legacy systems to Blockchain Deposit Accounts has a three- hour downtime over the weekend (3-6 p.m. EST every Saturday.) Enhancement is under development.
2 Transfers on the network are completed on a 24/7/365 and same day basis. Moving funds to and from the network from traditional Demand Deposit Accounts on legacy systems to Blockchain Deposit Accounts has a three- hour downtime over the weekend (3-6 p.m. EST every Saturday.) Enhancement is under development.

 

 

 

 

 

View source version on businesswire.com: https://www.businesswire.com/news/home/20260528577525/en/

 

Business Wire India

EZVIZ, a smart home brand driven by innovation, announced that it has received recognition from the distinguished Plus X Award as the Design Innovator 2026 in smart home technology. Having taken home two accolades with its flagship smart video doorphone HP7 and the smart entry family, the brand maintains a strong presence at the Plus X Award and has been selected by the jury as the winner in the smart home category this year. The award reaffirms EZVIZ’s achievement in bridging users’ genuine needs with cutting-edge innovation.

 

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260527895594/en/

 

 

 

“Innovation is ingrained in our DNA, giving us the power to push smart home beyond limits,” said Grant Chen, chief product officer at EZVIZ. “Users are EZVIZ’s anchor, reminding us that technology ultimately is to serve people for a better life. That’s why we can consistently design products with human care that are loved and trusted by families.”

 

Always at the forefront, EZVIZ dares to ditch the bulky housings of traditional home cameras and creates products that sophisticatedly balance technology, aesthetics, and lifestyle. Shaped by this philosophy is the exemplary multi-lens series, which integrates interlinked pan-tilt cameras with AI-powered detection in a compact housing that blends naturally with its surroundings. Sticking to this approach, it has recently developed 4G-WiFi switching cameras, keeping pace with the growing desire to stay connected with nature.

 

 

Beyond smart cameras, this innovation and balance also usher EZVIZ smart entry into an advanced era with scalability and reliability. The solidest practice is the star lineup – video doorphones that merge minimal design with cutting-edge local AI. Redefining intercoms with versatile functions and a refreshing visual language, EZVIZ’s video doorphones feature a slim outdoor panel for palm vein and face unlocking and enhanced awareness, and an indoor screen doubling as a central hub for flexible management.

 

 

Probably the first in the industry to integrate interactive video screens for enhanced safety and communication, smart locks also embody EZVIZ’s industry-leading design. Fitting in modern houses with its stylish appearance and refined materials, the flagship DL50FVS, for instance, enables facial recognition, remote access management, and two-way communication, ensuring seamless entry whenever needed. Intuitive comfort is further ensured by the easy-to-grab handle, allowing users to tilt it from either side without worrying about pinching their fingers.

 

 

 

 

View source version on businesswire.com: https://www.businesswire.com/news/home/20260527895594/en/

 

India’s energy transition is being driven by the country’s ambitious goal of achieving net zero emissions by 2070, with electric vehicles (EVs) playing a crucial role in this shift. Backed by key government initiatives and significant investments in EV infrastructure and manufacturing, the sector is witnessing rapid growth. As automakers, startups, and energy companies accelerate their focus on sustainable mobility, the demand for skilled apprentices and professionals in EV manufacturing is also rising steadily across India. 

Dr. Nipun Sharma, CEO, TeamLease Degree Apprenticeship, highlights seven emerging apprenticeship roles that are becoming critical in India’s EV ecosystem.

1. EV Battery Assembler
   Responsible for assembling battery packs, lithium-ion cells, and related components used in electric vehicles. Apprentices learn battery fitting, wiring, testing, and safety procedures.

2. EV Motor Assembler
   Works on assembling electric motors and related drivetrain components. The role involves fitting motor parts, testing performance, and ensuring proper alignment and functioning.

3. EV Charging Station Technician
   Assists in the installation, maintenance, and troubleshooting of EV charging stations. Apprentices gain hands-on experience with charging systems, electrical connections, and safety checks.

4. EV Service Technician
   Handles the diagnosis, repair, and maintenance of electric vehicles. This role includes inspecting battery systems, motors, wiring, and other EV components to ensure smooth functioning.

5. EV Production Line Associate
   Supports manufacturing and assembly line operations in EV plants. Responsibilities include component fitting, quality checks, machine handling, and maintaining production efficiency.

6. Quality Check Technician
   Ensures EV components and assembled vehicles meet quality and safety standards. Apprentices are trained in inspection processes, testing methods, and defect identification.

7. Wiring Harness Technician
   Responsible for assembling and fitting electrical wiring systems in EVs. The role involves cable routing, connector fitting, and ensuring proper electrical connections across vehicle systems.

As India’s EV industry expands, apprenticeship opportunities are becoming a key pathway for building a skilled workforce. These roles provide practical industry exposure and hands-on technical training, helping young professionals prepare for careers in the growing clean mobility sector.

Business Wire India

The biggest frustration in D2C marketing has never been a lack of data, it’s the gap between knowing what needs to change and actually making it happen. At Meta Day 2026, Strique unveiled the autonomous performance marketing execution platform built specifically for direct-to-consumer brands, marking a major shift in how modern D2C growth gets done.

 

Built by founders with experience managing over $100 million in marketing spend across high growth D2C brands, Strique transforms real world marketing intelligence into a platform designed to continuously optimise revenue and performance.

 

Strique is not a dashboard, reporting layer, or AI copywriting tool. It is a new operating layer for D2C growth teams where AI doesn’t just surface insights, it executes across the full marketing workflow. From auditing ad accounts and diagnosing underperforming campaigns to generating creatives, queuing campaign actions, and measuring outcomes, Strique closes the loop every other tool leaves open.

 

A founder or performance marketer simply gives Strique a plain-language growth brief. The system connects to Meta, Google, TikTok, Shopify, and CRM platforms, reads live performance signals, identifies wasted spend, reallocates budgets dynamically, generates creative directions, prepares campaign actions, and builds a structured execution plan.

 

What makes Strique different is its self-learning feedback loop across the full marketing and revenue stack. The platform learns not only from what drives growth, but also from what wastes spend, lowers ROAS and slows conversion.

 

Every campaign feeds the system with live performance intelligence across ads, creatives, audiences, email, landing pages, customer journeys, inventory movement and communication flows. Strique remembers what worked, what failed and what needs improvement, continuously optimising execution to drive stronger revenue outcomes with every cycle.

 

While most AI tools in marketing focus on isolated tasks like writing copy or summarising reports, Strique is designed to manage and optimise growth continuously across the entire revenue stack. As AI evolves from content generation into execution, platforms like Strique represent a shift from fragmented marketing workflows to self-learning systems capable of operating modern D2C growth engines at scale.

 

The launch comes at a defining moment for the D2C ecosystem. Growth has become more competitive, creative cycles move faster than ever, attribution is increasingly fragmented, and lean teams are expected to deliver at scale. At the same time, AI has evolved from content generation to reasoning, memory, tool use, and execution, making autonomous marketing systems possible for the first time.

 

Strique has already seen 500+ signups within the first 30 days of its latest version launch, signalling growing demand for AI systems that do more than just generate content. Early brands using the platform are already reporting strong business impact. INC5 improved ROAS by 21% within the first six weeks. CottonWorld increased revenue by 36%, while Crimzon delivered 32% revenue growth alongside significant ROAS improvement. One brand launched 127 Meta creatives in just 40 days while maintaining ROAS at scale, highlighting how AI driven execution is helping brands move faster without compromising performance.

 

Beyond performance metrics, Strique is helping founders, growth leaders, ecommerce teams and agencies dramatically increase marketing output without increasing headcount, unlocking a faster and more scalable approach to growth for both emerging and large scale D2C brands.

 

Vatsal Rajgor, Co-Founder & CEO, Strique, said: “The next wave of AI will not stop at generating content, it will manage and optimize growth itself. We believe modern marketing teams can no longer operate through fragmented tools, manual workflows and delayed execution cycles. Strique is built for that shift, a self learning platform that continuously improves revenue, ROAS and performance execution by learning from every campaign, customer interaction and outcome across the entire growth stack.”

 

The long-term vision for Strique is simple but ambitious: every D2C brand will eventually operate with an autonomous system that understands the brand, connects to its marketing stack, monitors performance, generates assets, launches with approval, and learns from every campaign. That future is no longer theoretical; it is already being built.

 

As AI reshapes global commerce, Strique represents a new benchmark, not measured by how much content AI can generate, but by how effectively it can drive measurable business outcomes. For D2C brands, Strique turns growth intent directly into execution.

 

Business Wire India

 

• RLS-1496 is an investigational, first-in-class, disease-modifying, selective glutathione peroxidase 4 (GPX4) modulator that targets pathologic senescent and other stressed, aging cells that drive chronic, age-dependent diseases, such as AK, and represents a novel drug category — Adaptive SenoTherapeutics
• In recognition of May as Skin Cancer Awareness Month, Rubedo is calling attention to the myths and facts surrounding AKs — and to the urgent need for a new generation of treatments that are effective without the side-effect burden of today’s options

 

Rubedo Life Sciences, Inc. (Rubedo), an AI-driven, clinical-stage biotech focused on selective cellular rejuvenation medicines targeting aging cells, today announced preliminary results from a Phase 1b/2a study of RLS-1496 in patients with actinic keratosis (AK), a common age-related condition resulting in precancerous skin lesions, that is most commonly seen after age 65.¹ The open-label multi-center trial, conducted in the United States, assessed the safety, tolerability, and clinical effects of RLS-1496 1% cream in adult patients with AK on the forearms. RLS-1496 is the first selective glutathione peroxidase 4 (GPX4) modulator to be studied in human trials, and the first targeting cellular rejuvenation as a new therapeutic pathway in a novel category called Adaptive SenoTherapeutics. Interim data from the study were presented at the RBC Capital Markets Global Healthcare Conference in New York City on May 19, 2026.

 

Preliminary RLS-1496 Actinic Keratosis Trial Results

 

 

• The Phase 1b/2a study of RLS-1496 showed a 46% reduction in AK count compared to 11% for untreated control at 4 weeks in the first 18 of 24 patients evaluated
• RLS-1496 was associated with favorable safety, with no serious adverse events (AEs) and no discontinuations due to AEs during the 4-week study
• RLS-1496 was well-tolerated, causing minimal local irritation, an area of high unmet need in the standard of care
• A Phase 2b dose-ranging AK study for RLS-1496 will begin in Q4

 

“A 46% reduction in AK lesions at four weeks, achieved with minimal irritation, is exciting since so many patients are hesitant to use current treatments due to redness, peeling, pain, and weeks-long recovery,” said Rubedo CEO Frederick Beddingfield, III, MD, PhD, FAAD, who is also a practicing dermatologist. “AKs are precancerous lesions that lead to squamous cell carcinoma, and patients deserve a therapy that is designed to be both effective and tolerable. We look forward to advancing RLS-1496 for AKs, as well as continuing its development in psoriasis, atopic dermatitis, photo-aging, and other degenerative diseases and conditions associated with the aging process.”

 

These AK data results follow the preliminary results from Rubedo’s recently completed Phase 1b clinical trial, conducted in the European Union, which assessed the safety, tolerability, clinical effects, plasma bioavailability, and pharmacodynamics of topical RLS-1496. This single-center, ascending-dose, randomized, double-blind, vehicle-controlled trial in patients with plaque psoriasis, atopic dermatitis, and skin aging (photo-aged skin) met its primary safety endpoint, with RLS-1496 also demonstrating early signs of efficacy, including a remarkable 20% decrease in epidermal thickness in psoriasis patients on therapy compared to a 30% increase with patients on vehicle.²

 

 

“The preliminary results from this AK trial, coupled with those from our Phase 1 trial in patients with plaque psoriasis, atopic dermatitis, and skin aging, show continued promise for RLS-1496 as the first GPX4 modulator and a new class of Adaptive SenoTherapeutics,” said Rubedo Chief Scientific Officer and Founder Marco Quarta, PhD. “By clearing damaged senescent cells and restoring the health of stressed but viable cells, we aim to address biological aging at its cellular root, with implications that extend well beyond dermatology to fibrosis, metabolic disease, sarcopenia, and neurodegeneration. What makes RLS-1496 particularly exciting is that it appears to act across several fundamental hallmarks of aging — from cellular senescence to autophagy and oxidative stress imbalance. This is the kind of multi-axis biology we believe will define the next generation of true longevity medicines.”

 

 

The data from Rubedo’s RLS-1496 AK trial, as well as data from the Phase 1b trial, including a comprehensive data set of 70 subjects assessing RLS-1496 in aging skin, are being compiled for submission to major medical journals and medical meetings.

 

 

Actinic Keratosis: A Common Health Condition with an Unmet Need

 

 

It is estimated that 58 million Americans have one or more AKs.³ The U.S. annual market size for AKs was $3.55 billion in 2025, and will grow to $4.8 billion by 2035.⁴ In recognition of Skin Cancer Awareness Month, Rubedo is calling attention to common myths that are believed about AKs and highlighting why new treatments are still urgently needed for the millions of people affected by AKs.

 

 

Myth 1: AKs are harmless sun spots and usually go away on their own.

 

The Facts:

 

 

• AKs form as a result of long-term sun exposure, and often appear as small, rough patches of skin that can vary in color. They typically are found on sun-exposed areas of the body, including the face, scalp, neck, arms, and hands.³
• Left untreated, AKs can progress into squamous cell carcinoma (SCC), which is the second most common skin cancer.⁵ An estimated 1.8 million cases of SCC are diagnosed each year,⁶ and it is estimated that 82% of SCCs begin as AKs.⁵

 

 

Myth 2: AKs are rare.

 

The Facts:

 

 

• AKs are among the most common diagnoses made by dermatologists, with a global prevalence of approximately 14%.⁷ The prevalence of AK increases with age, frequently developing after age 50 but most commonly seen after age 65.¹
• While a single lesion carries a relatively low risk of progression, the presence of one AK indicates a higher likelihood of developing additional lesions over time, increasing the cumulative risk of skin cancer.³

 

 

Myth 3: Current AK treatments are good enough.

 

The Facts:

 

 

• Available treatments — including topical creams, cryosurgery, and photodynamic therapy — can be effective but are often associated with pain, redness, swelling, crusting, or peeling that can take weeks to heal.⁸
• These side effects lead some patients to delay or discontinue treatment, leaving lesions untreated and increasing the risk that AKs progress to skin cancer.⁸ New effective treatment approaches with improved tolerability are needed to protect patients from preventable cancer.

 

 

About RLS-1496 and GPX4 Modulation

 

Rubedo’s lead candidate RLS-1496, being developed for topical and oral administration, is a first-in-class, disease-modifying GPX4 modulator selectively targeting pathologic senescent and other stressed, aging cells that drive chronic, age-dependent diseases. These include immunology and inflammation (I&I), dermatology and skin aging, metabolic syndrome (obesity, diabetes, liver fibrosis), sarcopenia, and neurodegenerative disease.

 

 

In certain pathologic cells, aging is associated with an imbalance in GPX4. Modulation of GPX4 sensitizes cells to ferroptosis, which is a type of programmed cell death and is believed to be an Achilles heel of senescent cells. By modulating GPX4 in ferroptosis-sensitive senescent “aged” cells, RLS-1496 may be able to clear these cells to fight disease and also support healthy cells to function properly and restore tissue homeostasis. Beyond its targeted senolytic function in triggering selective ferroptosis within pathological senescent cells, RLS-1496 could also act as a restorative modulator that induces a vital ‘redox-reset’ through a controlled hormetic response in stressed neighboring cells, effectively clearing the source of chronic inflammation while actively re-establishing healthy tissue homeostasis. This dual-action mechanism represents a novel drug category—Adaptive SenoTherapeutics.

 

 

RLS-1496 uses Rubedo’s proprietary, AI-driven drug discovery platform ALEMBIC™, which identifies targets within pathologic senescent cells and develops selective cellular rejuvenation medicines for these targets.

 

 

About Rubedo Life Sciences

 

 

Rubedo Life Sciences is a clinical-stage biotech developing a broad portfolio of innovative selective cellular rejuvenation medicines targeting aging cells that drive chronic age-related diseases. Our proprietary AI-driven ALEMBIC™ drug discovery platform is developing novel first-in-class small molecules to selectively target pathologic and senescent cells, which play a key role in the progression of pulmonary, dermatological, oncological, neurodegenerative, fibrotic, and other chronic disorders. Our lead drug candidate – RLS-1496, a potential first-in-class disease-modifying GPX4 modulator – is currently in Phase I clinical trials. The Rubedo leadership team is composed of industry leaders and early pioneers in chemistry, AI technology, longevity science, and life sciences, with expertise in drug development and commercialization from both large pharmaceutical and leading biotechnology companies. The company is headquartered in Mountain View, CA, USA, and has offices in Milan, Italy. For additional information, visit www.rubedolife.com.

 

 

¹ Flohil SC, van der Leest RJT, Dowlatshahi EA, et al. Prevalence of Actinic Keratosis and Its Risk Factors in the General Population: The Rotterdam Study. Journal of Investigative Dermatology, Volume 133, Issue 8, 2013, Pages 1971-1978, https://doi.org/10.1038/jid.2013.134

 

 

² Vitari A, Laslavic A, Spellman M, et al. Abstract 0510: Clinical study of RLS-1496 topical cream: Targeting cellular senescence in patients with mild-to-moderate plaque psoriasis. Presented at 2026 Annual Meeting of the Society for Investigative Dermatology (SID). https://www.sidnet.org/wp-content/uploads/2026/05/SID_Chcago26_Abstract_FInal_4.pdf#page=132

 

 

³ The Skin Cancer Foundation. Actinic Keratosis Overview. Accessed May 2026. https://www.skincancer.org/skin-cancer-information/actinic-keratosis/

 

 

⁴ Nova1Advisor. U.S. Actinic Keratosis Treatment Market Size, Share & Trends Analysis Report By Therapy (Topical/Drugs, Surgery, Photodynamic Therapy), By Drug Class, By Product, By End-use, And Segment) – Industry Analysis, Share, Growth, Regional Outlook and Forecasts, 2026-2035. Accessed May 2026. https://www.novaoneadvisor.com/report/us-actinic-keratosis-treatment-market

 

 

⁵ Li Z, Lu F, Zhou F, et al. (2025). From actinic keratosis to cutaneous squamous cell carcinoma: the key pathogenesis and treatments. Frontiers in immunology, 16, 1518633. https://doi.org/10.3389/fimmu.2025.1518633

 

 

⁶ The Skin Cancer Foundation. Squamous Cell Carcinoma Overview. Accessed May 2026. https://www.skincancer.org/skin-cancer-information/squamous-cell-carcinoma/

 

 

⁷ George CD, Lee T, Hollestein LM, et al. Global epidemiology of actinic keratosis in the general population: a systematic review and meta-analysis, British Journal of Dermatology, Volume 190, Issue 4, April 2024, Pages 465–476, https://doi.org/10.1093/bjd/ljad371

 

 

⁸ Balcere A, Rone Kupfere M, Čēma I, Krūmiņa A. (2019). Prevalence, Discontinuation Rate, and Risk Factors for Severe Local Site Reactions with Topical Field Treatment Options for Actinic Keratosis of the Face and Scalp. Medicina (Kaunas, Lithuania), 55(4), 92. https://doi.org/10.3390/medicina55040092

 

 

 

 

View source version on businesswire.com: https://www.businesswire.com/news/home/20260528143952/en/

 

Increasing interest in science-backed ingredients positions Singapore as a key gateway for European dairy innovation in Southeast Asia 

SINGAPORE, May 29 - The European Union is strengthening its engagement with Singapore as a regional hub for advanced food manufacturing and nutrition innovation. This comes as demand for functional dairy ingredients accelerates across Southeast Asia.  

Led by Bord Bia – The Irish Food Board, the initiative is part of the “European Dairy: Ireland, Where Nature Meets Science” campaign, a €3.2 million investment co-funded by the European Union to strengthen Asia’s nutrition pipeline and foster long-term trade partnerships. The campaign showcases sustainable farming and scientific research behind European dairy production.  

Singapore is a Strategic Gateway for Functional Nutrition in Asia 

Singapore is globally recognised as a hub for innovation, positioned at the heart of Southeast Asia’s food ecosystem, and has an important role in regional product development and distribution. Manufacturers across ASEAN are increasingly seeking high-quality science-backed ingredients, as demand for targeted life-stage nutrition, preventative health products and functional foods is increasing. This is largely driven by the fact that Southeast Asia’s population is growing and aging rapidly, particularly in Singapore, leading to increased demand for functional foods to support healthy aging and overall wellbeing. Given limited domestic dairy production in Singapore, F&B innovators and manufacturers are driven to rely on imports and seek trusted international partners. 

Ms. Lorna Allen, South East Market Manager of Bord Bia, mentioned, “Singapore is a key gateway for European dairy engagement in Southeast Asia, particularly as demand for functional and science-backed nutrition continues to grow. Ireland has exported €276 million value of dairy products to Southeast Asia in 2025, a y-o-y increase of 16.4%. Through the EU-funded campaign, Bord Bia is supporting closer collaboration between European dairy producers from Ireland and regional food and nutrition innovators.” 

Dr Kalpana Bhaskaran, Deputy Director, industry partnerships and Head, Glycemic Index Research Unit at Temasek Polytechnic, commented, “Dairy ingredients play a vital role across the life course. With protein‑fortified and functional dairy products gaining strong momentum, the opportunity to improve population health through evidence‑based dairy innovation has never been greater.” 

A Science-Led Advantage Supporting Industry Needs 

European dairy from Ireland combines a natural grass-fed, pasture-based system with the support of advanced scientific research. This combination of natural production methods and scientific validation allows European dairy to meet the performance and quality requirements of manufacturers across Asia. 

Dr. André Brodkorb, Senior Researcher, Teagasc Food Research Centre Moorepark, said, “Irish grass‑fed milk is scientifically proven to deliver superior nutritional benefits, with Teagasc research showing dairy cows who operate on an Irish grass-fed system, produced milk with higher percentages of omega-3 and conjugated linoleic (CLA) fatty acids compared to cows fed medium and low proportions of grass.” 

European Dairy Powders at FHA Singapore 2026 

Bord Bia brought leading European dairy suppliers from Ireland to Food & Hospitality Asia (FHA) in Singapore last April. Industry professionals attending FHA Singapore were invited to explore partnership opportunities and discover how European dairy from Ireland is supporting the next generation of nutrition solutions in Asia. Bord Bia focused on:  

• Functional dairy ingredients designed for sports nutrition, healthy ageing, life-stage nutrition, and foodservice. 

• Solutions that support product innovation for Asian consumers. 

• Opportunities to connect directly with suppliers for sourcing and collaboration. 

Strengthening Collaboration Across the Region 

As part of the European Union’s engagement in Singapore, Bord Bia is also facilitating a closed-door industry session bringing together stakeholders from research, development, and manufacturing. This reflects ongoing collaboration between European dairy stakeholders and regional partners, including organisations such as Temasek and Teagasc, to support innovation and knowledge exchange in functional nutrition.

Business Wire India

ExaGrid®, the world’s largest independent backup storage vendor providing Tiered Backup Storage with the most Comprehensive Security and AI-Powered Retention Time-Lock for Ransomware Recovery, today announced that company was honored with five industry awards, including Air-gapped Ransomware Recovery Product of the Year, Bench Tested Product of the Year, Company of the Year, Data Protection Product of the Year, and the Storage Product of the Year during the Network Computing Awards ceremony, held in London on May 21, 2026.

 

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260528849813/en/

 

 

 

The Network Computing Awards are determined by public vote. The 2026 awards mark the eighth consecutive year of wins for ExaGrid at the Network Computing Awards, and the seventh consecutive year that ExaGrid has won the Company of Year award. ExaGrid was awarded the “Bench Tested Product of the Year” by judges after an independent product review of the ExaGrid Tiered Backup Storage SSD and HDD appliances with AI-Powered Retention Time-Lock for Ransomware Recovery.

 

ExaGrid continues to gain recognition for its Tiered Backup Storage, winning seven industry awards so far in 2026, including:

 

 

• StorageNewsletter Awards – Secondary Storage award
• Data Breakthrough Awards – Data Backup Solution of the Year
• Network Computing Awards – Air-gapped Ransomware Recovery Product of the Year
• Network Computing Awards – Bench Tested Product of the Year
• Network Computing Awards – Company of the Year
• Network Computing Awards – Data Protection Product of the Year
• Network Computing Awards – Storage Product of the Year

 

 

“Congratulations to all of the winners of the Network Computing Awards 2026, and many thanks to everyone who voted for us, we are grateful to our partners and customers for their support,” said Bill Andrews, President and CEO of ExaGrid. “We are honored that our Tiered Backup Storage has been recognized with the Air-gapped Ransomware Recovery Product of the Year award again this year, as we have built upon our AI-Powered Retention Time-Lock for Ransomware Recovery to include Auto Detect & Guard, in addition to a tiered air gap, delayed deletes, and immutable data objects. We are especially honored to win Company of the Year for the seventh time, and also the Bench-Tested Product of the Year based on the review of our newest appliances models. We continue to innovate to offer organizations the best backup storage in the industry, and we are grateful for this recognition.”

 

About ExaGrid
ExaGrid provides Tiered Backup Storage with a unique disk-cache Landing Zone, long-term retention repository, scale-out architecture, and comprehensive security features, including AI-Powered Retention Time-Lock to recover from a ransomware attack. ExaGrid’s Landing Zone provides for the fastest backups, restores, and instant VM recoveries. The Repository Tier offers the lowest cost for long-term retention. ExaGrid’s scale-out architecture includes full appliances and ensures a fixed-length backup window as data grows, eliminating expensive forklift upgrades and forced product obsolescence. ExaGrid offers the only two-tiered backup storage approach with a non-network-facing tier (tiered air gap), delayed deletes, and immutable objects to recover from ransomware attacks.

 

 

ExaGrid has physical sales and pre-sales systems engineers in the following countries: Argentina, Australia, Benelux, Brazil, Canada, Chile, CIS, Colombia, Czech Republic, France, Germany, Hong Kong, India, Israel, Italy, Japan, Mexico, Nordics, Poland, Portugal, Qatar, Saudi Arabia, Singapore, South Africa, South Korea, Spain, Turkey, United Arab Emirates, United Kingdom, United States, and other regions.

 

 

Visit us at exagrid.com or connect with us on LinkedIn. See what our customers have to say about their own ExaGrid experiences and learn why they now spend significantly less time on backup storage in our customer success stories. ExaGrid is proud of our +81 NPS score!

 

 

ExaGrid is a registered trademark of ExaGrid Systems, Inc. All other trademarks are the property of their respective holders.

 

 

 

 

View source version on businesswire.com: https://www.businesswire.com/news/home/20260528849813/en/

 

Turning Unskippable Moments into Playable Ones with a Chewy Snack Drink Experience 

BANGKOK, May 29: Sappe Public Company Limited (SAPPE), a leading innovator in beverages from Thailand and the creator of the global “Snack Drink” category, continues to energize the international market with the launch of its latest global campaign for “Mogu Mogu” under the concept “Wanna Skip? You Gotta Chew.” The campaign invites Generation Z worldwide to keep going through life’s unskippable moments simply by drinking and chewing “Mogu Mogu,” transforming everyday challenges into enjoyable and manageable experiences while reinforcing the brand’s position as a global snackable drink that brings fun into every moment. 
 

 

As a fruit juice with nata de coco beverage that has pioneered a unique category and achieved market leadership in several countries, including the Philippines, South Korea, and the United Kingdom (based on NIQ data), “Mogu Mogu” continues to differentiate itself through its signature “Tangible Fun” experience, combining refreshing fruit flavors with its iconic chewy coconut jelly. Beyond enjoyment, the act of chewing is also associated with a sense of relaxation, making it a natural companion for moments that feel beyond control. The campaign builds on a key insight into Generation Z, who have grown up in a digital world where they can easily skip unwanted content, yet cannot skip real-life situations. “Mogu Mogu” steps in as a simple yet meaningful solution, helping them navigate those moments in their own way through a playful and sensory drinking experience. 

 

Ms. Piyajit Ruckariyapong, Chief Executive Officer of Sappe Public Company Limited, said, “Generation Z is a powerful force shaping global trends. They value experiences, fun, and authenticity. The ‘Wanna Skip? You Gotta Chew’ campaign reflects our deep understanding of their behavior. ‘Mogu Mogu’ is not just a beverage; it is an experience that helps consumers navigate everyday moments in a fun and natural way. This aligns with our ambition to grow a Thai brand into a truly global brand that resonates with consumers across diverse markets.” 
 

The campaign adopts a 360-degree strategy across both online and offline channels. Digitally, it leverages full-scale social media engagement and influencer collaborations in each market to drive awareness and participation. On-ground, the brand activates sampling and immersive brand experiences across key markets, including the Philippines, South Korea and the United Kingdom, bringing consumers closer to the brand and reinforcing emotional connections. This global rollout reflects SAPPE’s vision to elevate “Mogu Mogu” beyond refreshment into a “moment of tangible fun” that fits seamlessly into everyday life. 

 “Mogu Mogu” is one of SAPPE’s flagship brands and a pioneer of the “Snack Drink” category, being the world’s first fruit juice beverage with nata de coco. Today, the brand is available in over 100 countries worldwide, known for its wide variety of flavors and distinctive chewy texture that sets it apart. With its strong global presence and continuous innovation, “Mogu Mogu” continues to win the hearts of consumers and strengthen its position as a fast-growing global brand. For more information and updates, follow “Mogu Mogu” on TikTok and Instagram, or visit www.mogumogu.com.